Effects of Tele Speech Therapy on the Treatment of Stammering in Adults Who Stutter

July 14, 2025 updated by: Riphah International University
The aim of the study is to determine the effectiveness of telespeech therapy on the treatment of stammering.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab
      • Lahore, Punjab, Pakistan, 54000
        • Muaz Medical Complex

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Both Genders
  • Adults With stuttering 15 to 40 years according to WHO criteria

Exclusion Criteria:

- Stammering with any comorbid are excluded eg. Visual and Hearing Impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tele therapy
The experimental group will be given teletherapy, total number of 2 sessions per week, each participant comprising 30 minutes.
Other: Teletherapy
A teletherapy patient presenting with stammering (stuttering) is a person receiving speech therapy remotely, using technology like video conferencing, to address speech fluency difficulties, often including repetitions, prolongations, or blocks in speech.
Active Comparator: Traditionally speech therapy
Traditional therapy will be given a total of 2 sessions per week to each participant, comprised of 30 minutes
Other: Traditionally speech therapy
This type of intervention is traditional speech therapy that will be given to stammering adults, to address speech fluency difficulties, often including repetitions, prolongations, or blocks in speech.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stuttering Severity Instrument - Fourth Edition (SSI4)
Time Frame: Base line and 6 weeks

The Stuttering Severity Instrument-Fourth Edition (SSI-4) is a norm-referenced assessment used to quantify stuttering severity in children and adults, measuring frequency, duration, physical concomitants, and the naturalness of speech.

The total score measures the overall severity of the individual's stuttering disorder. The examiner adds scores from the frequency, duration, and physical concomitants sections to obtain the severity score and percentile rank. These are calculated using the tables within the record form. These tables also convert scores to a severity equivalent, which ranges from "very mild" to "very severe".

It has a total score range of 0 to 20 for physical concomitants, and 2 to 18 for frequency and duration. The total score for the entire instrument is the sum of these three scores, making the overall range up to 20 + 18 + 18 = 56.
Base line and 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Mamona Riaz, M.S, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 20, 2025

Primary Completion (Actual)

June 20, 2025

Study Completion (Actual)

June 29, 2025

Study Registration Dates

First Submitted

April 7, 2025

First Submitted That Met QC Criteria

April 17, 2025

First Posted (Actual)

April 22, 2025

Study Record Updates

Last Update Posted (Actual)

July 15, 2025

Last Update Submitted That Met QC Criteria

July 14, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/RCR&AHS/24/0664

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stammering

Clinical Trials on Teletherapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe